Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of Acute Hemeolytic Anaemia (AHA)

Journal article

Peer reviewed

European review for medical and pharmacological sciences, Vol.24(15), pp.7923-7924

01/08/2020

PMID: 32767316

Abstract

Life Sciences & Biomedicine

Pharmacology & Pharmacy

Science & Technology

1 Record Views

Title: Hydroxychloroquine (HCQ) use in G6PD deficient COVID-19 patients and the risk of Acute Hemeolytic Anaemia (AHA)
Creators - without role: S. A. Dar - Jazan University
M. Wahid - Jazan University
S. Haque - Jazan University
S. S. Almalki - College Station Medical Center
N. Akhter - College Station Medical Center
Publication Details: European review for medical and pharmacological sciences, Vol.24(15), pp.7923-7924
Publisher: Verduci Publisher
Number of pages: 2
Identifiers: 9912066108331
Academic Unit: Al Baha University; Jazan University
Language: English
Resource Type: Journal article